BioGenesis has developed a sensor and measurement system for early diagnosis of Alzheimer disease using a small amount of blood. There is a very low concentration of Alzheimer markers in the blood due to the membrane separating the brain and blood vessels. To solve this problem, a sensor that is 10,000 times more accurate than the existing technology has been developed to precisely measure the dementia markers in the blood.
We develop a diagnostic kit that can detect Alzheimer disease before its symptoms appear and monitor its progress by simply and inexpensively testing dementia using blood.
It will be registered as a health checkup item in the future and will be a scaffolding technology that can overcome Alzheimer by periodically inspecting once or twice a year.
Company Name: BioGeneSys Inc.
Foundation Date: Jun 25. 2018
CEO: Shim Joon Sub
Address: Chmbit-gwan Rm# 609, Kwangwoon-Ro 20, Nowon-gu, Seoul